Cresanto Global Limited (BOM:531207)
5.37
0.00 (0.00%)
At close: Sep 21, 2026
Cresanto Global Revenue
Cresanto Global had revenue of 539.00K INR in the twelve months ending June 30, 2026, down -89.75% year-over-year. In the fiscal year ending March 31, 2026, Cresanto Global had annual revenue of 539.00K. That makes Cresanto Global the 47,418th largest company in the world by revenue and 5,306th in India.
Revenue
539.00K
Revenue Growth
-89.75%
P/S Ratio
42.58
Revenue / Employee
107.80K
Employees
5
Market Cap
22.95M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 539.00K | - | - |
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | 206.32K | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vivanza Biosciences | 1.17B |
| Beryl Drugs | 213.23M |
| Fabino Enterprises | 208.42M |
| Brawn Biotech | 172.59M |
| Unjha Formulations | 152.79M |
| Decipher Labs | 138.51M |
| Ganga Pharmaceuticals | 28.28M |
| Emmessar Biotech & Nutrition | 23.78M |